PNC Financial Services Group Inc. Acquires 2,380 Shares of Henry Schein, Inc. (NASDAQ:HSIC)

PNC Financial Services Group Inc. raised its stake in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 2.8% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 86,143 shares of the company’s stock after acquiring an additional 2,380 shares during the quarter. PNC Financial Services Group Inc.’s holdings in Henry Schein were worth $6,280,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also made changes to their positions in the stock. American Century Companies Inc. lifted its stake in shares of Henry Schein by 3.1% during the 2nd quarter. American Century Companies Inc. now owns 5,484,286 shares of the company’s stock worth $351,543,000 after purchasing an additional 162,477 shares during the last quarter. Swedbank AB purchased a new stake in shares of Henry Schein during the first quarter valued at about $215,998,000. Nuance Investments LLC boosted its holdings in shares of Henry Schein by 6.2% in the 2nd quarter. Nuance Investments LLC now owns 1,863,333 shares of the company’s stock valued at $119,440,000 after buying an additional 108,143 shares in the last quarter. Burgundy Asset Management Ltd. grew its position in shares of Henry Schein by 1.0% in the 2nd quarter. Burgundy Asset Management Ltd. now owns 1,640,379 shares of the company’s stock worth $105,148,000 after buying an additional 16,476 shares during the last quarter. Finally, Dimensional Fund Advisors LP raised its stake in shares of Henry Schein by 10.1% during the 2nd quarter. Dimensional Fund Advisors LP now owns 1,634,384 shares of the company’s stock worth $104,764,000 after acquiring an additional 149,517 shares in the last quarter. 96.62% of the stock is currently owned by hedge funds and other institutional investors.

Henry Schein Stock Up 1.8 %

NASDAQ:HSIC opened at $75.08 on Friday. The company has a debt-to-equity ratio of 0.46, a current ratio of 1.42 and a quick ratio of 0.82. The company’s fifty day moving average price is $70.89 and its 200-day moving average price is $69.76. Henry Schein, Inc. has a 1-year low of $63.67 and a 1-year high of $82.63. The firm has a market capitalization of $9.36 billion, a P/E ratio of 30.90, a PEG ratio of 2.12 and a beta of 0.87.

Henry Schein (NASDAQ:HSIC) last released its quarterly earnings data on Tuesday, November 5th. The company reported $1.22 earnings per share for the quarter, beating analysts’ consensus estimates of $1.17 by $0.05. The business had revenue of $3.17 billion during the quarter, compared to analyst estimates of $3.24 billion. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The company’s revenue was up .4% on a year-over-year basis. During the same quarter last year, the business posted $1.32 EPS. As a group, equities research analysts anticipate that Henry Schein, Inc. will post 4.78 EPS for the current year.

Insider Activity at Henry Schein

In other news, SVP Lorelei Mcglynn sold 21,035 shares of the firm’s stock in a transaction that occurred on Friday, September 6th. The shares were sold at an average price of $69.30, for a total transaction of $1,457,725.50. Following the sale, the senior vice president now owns 71,833 shares of the company’s stock, valued at $4,978,026.90. This trade represents a 22.65 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, COO Michael S. Ettinger sold 12,240 shares of the business’s stock in a transaction on Monday, November 18th. The shares were sold at an average price of $75.00, for a total transaction of $918,000.00. Following the completion of the transaction, the chief operating officer now owns 87,706 shares of the company’s stock, valued at approximately $6,577,950. This represents a 12.25 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.14% of the stock is owned by company insiders.

Wall Street Analysts Forecast Growth

Several equities research analysts have weighed in on the stock. UBS Group lowered their target price on shares of Henry Schein from $75.00 to $72.00 and set a “neutral” rating for the company in a research note on Wednesday, August 7th. Evercore ISI upped their target price on Henry Schein from $70.00 to $74.00 and gave the company an “in-line” rating in a research report on Tuesday, October 8th. JPMorgan Chase & Co. decreased their price target on Henry Schein from $88.00 to $80.00 and set an “overweight” rating for the company in a research note on Monday, August 12th. StockNews.com upgraded shares of Henry Schein from a “sell” rating to a “hold” rating in a report on Thursday, November 7th. Finally, Barrington Research reiterated an “outperform” rating and issued a $82.00 target price on shares of Henry Schein in a research note on Wednesday, November 6th. Six investment analysts have rated the stock with a hold rating, five have given a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $78.89.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.